Tenofovir Disoproxil Fumarate By Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd.

Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. It came from a subsidiary company of China National Pharmaceutical Industry Company affiliated to China National Pharmaceutical Group (CNPIC). With years development, BJ Zhongshuo has become a fast growing Joint-stock enterprise. BJ Zhongshuo runs a medicine R&D centre in Beijing Economic-Technological Development Area with over 20 experienced specialists and a batch of advanced equipment for experiment and detection. The centre deals with the R&D for innovated drugs and Generic drugs as well as the optimization and improvement on existing products. The R&D centre is now able to deal with 10-15 new products per year, for which provide strong supports to the development of the company. By running effective cooperation model, BJ Zhongshuo has set up numbers of production bases in different cities, including Jinzhou, Zhangjiakou, Heze, XiAcA A anA A A Changzhou, Zhenjiang and Dagang Industrial park in Tianjin. Some of the bases have gained GMP certificates and some are on the progress for the accreditation. For those products without GMP certificates, they are produced in GMP accredited workshops. Our target is to have over 80% products with GMP certificate and partial production being accredited by FDA of the U.S.A. or CEP of European Union. BJ Zhongshuo runs a Sales Center in Beijing, focus on selling specialized APIs and pharmaceutical intermediates. The over 100 main products fall into anti-tumour, anti-virus, Cardiovascular and cerebrovascular, Nervous system and antibiotics, etc. partial products are developed and produced independently, partial ones are developed and produced together with domestic laboratories, institutions and factories, and the rest are the represented useful and specialized products from other domestic enterprises. Based on the international and domestic demands, BJ Zhongshuo has focused its main products on 4 categories: cancer, cardiovascular disease, elderly frequently-occurring diseases and others of which BJ Zhongshuo has tracked good sales The strengths of BJ Zhongshuo include the seamless connection between the high efficient drug development and medium-small batch production on new drugs, as well as the mass production on various pharmaceutical intermediates which required by the market. Work with BJ Zhongshuo for Cooperation, Development and Win-together! Contact: Beijing ZhongShuo Pharmaceutical Technology Development Co.,Ltd. Address:NPCPI 16,Section 7 HePingLi Street,DongCheng District Beijing City,China. (Post Code: 100013) Office Direct Line: 0086-10-64430626 Mobile / Wechat / Whatsapp: 0086-17701087213 QQ: 1634598778 Email: sales.1@chinazhongshuo.com michellepeng0891@gmail.com sales.1@chinazhongshuo.com 1634598778@QQ.COM Zhongshuo2001@gmail.com WebsiteA A A www.chinazhongshuo.com